Gemtuzumab ozogamicin 是一种抗体偶联药物，由一种针对CD33的单克隆抗体组成，该单克隆抗体与 Calicheamicin 的细胞毒性衍生物相连。Gemtuzumab ozogamicin 可用于急性髓系白血病的研究。
| 生物活性 | Gemtuzumab ozogamicin is an antibody-drug conjugate(ADC)consisting of a monoclonal antibody targetingCD33linked to a cytotoxic derivative of Calicheamicin. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Store at 4°C, do not freeze |
m.cnreagent.com